Video Animation Explores Risks of Treating Life as a Machine
By ETC Group,
ETC Group
| 10. 29. 2014
MONTREAL, 29 Oct. 2014–On the eve of the largest annual gathering of synthetic biologists in the world, ETC Group and the Bioeconomies Media Project are launching a new animated explanation of the workings of this emerging “SynBio” industry, often dubbed extreme genetic engineering. Thousands of scientists, students and vendors will converge at the International Genetically Engineered Machines (iGEM) Jamboree in Boston to share the latest advancements in what has become a multi billion dollar industry based on the industrialization of life at the molecular level.
Increasingly, scientists and civil society are sounding the alarm about the risks posed by unregulated commercialization of SynBio’s untested, experimental and unprecedented manipulation of life forms. The new ten minute video, produced in collaboration with award-winning Canadian animator Marie-Josée Saint-Pierre and narrated by ETC’s Jim Thomas, is the first output from a new Bioeconomies Media Project. Featuring work of researchers from Canadian universities and funded by the Canadian Social Sciences and Humanities Research Council, the video provides a succinct introduction to the science and emerging industry of synthetic biology as well as some of...
Related Articles
By Alfonso Martinez Arias, Nicolas Rivron, and Naomi Moris, BioNews | 04.20.2026
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...
By Peter Ward, Slate | 03.30.2026
I’m in a cramped examination room at a clinic in Panama City. The lights are dim, and calming classical music plays from built-in speakers. A nurse has injected a dose of stem cells into Kenneth Scott through an IV in...
By Emily Mullin, Wired | 03.23.2026
As the Trump administration phases out the use of animal experimentation across the federal government, a biotech startup has a bold idea for an alternative to animal testing: nonsentient “organ sacks.”
Bay Area-based R3 Bio has been quietly pitching the...